Hemagen Diagnostics Analysis

Hemagen Pink Sheet Analysis Notes

The company recorded a loss per share of 0.06. Hemagen Diagnostics had not issued any dividends in recent years. Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company was founded in 1985 and is based in Columbia, Maryland. Hemagen Diagnostics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 15 people.The quote for Hemagen Diagnostics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Hemagen Diagnostics call William Hales at 443-367-5500 or check out https://www.hemagen.com.

Hemagen Diagnostics Investment Alerts

Hemagen Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 387.51 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hemagen Diagnostics's market, we take the total number of its shares issued and multiply it by Hemagen Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Hemagen Profitablity

The company has Profit Margin (PM) of (0.22) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.11.

Hemagen Diagnostics Outstanding Bonds

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Hemagen Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hemagen shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Hemagen Diagnostics. By using and applying Hemagen Pink Sheet analysis, traders can create a robust methodology for identifying Hemagen entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

If you are still planning to invest in Hemagen Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hemagen Diagnostics' history and understand the potential risks before investing.